The novel llama‐human chimeric antibody has potent effect in lowering LDL‐c levels in <i>hPCSK9</i> transgenic rats

Xinyang Li(BGI Group (China)), Naibo Yang(BGI Group (China)), Xiaopan Liu(Fujian Academy of Agricultural Sciences), Yong Hou(BGI Group (China)), Meiniang Wang(BGI Group (China)), Shuang Yang(Soochow University), Chuxin Liu(BGI Group (China)), Haitao Xiang(BGI Group (China)), Bo Li(BGI Group (China)), Xinhua Zhang(Sun Yat-sen University), Xiuqing Zhang(BGI Group (China)), Mi Huang(Lund University), Lin Jiang(Fudan University Shanghai Cancer Center), Yingying Ma(Northeast Agricultural University), Xiaoyan Gao(Shanghai Jiao Tong University)
Clinical and Translational Medicine
January 1, 2020
Cited by 14


Related Papers